Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial
Background: Patients with heart failure with preserved ejection fraction have significant
impairment in health-related quality of life. In the EMPEROR-Preserved trial (Empagliflozin …
impairment in health-related quality of life. In the EMPEROR-Preserved trial (Empagliflozin …
A comprehensive population‐based characterization of heart failure with mid‐range ejection fraction
Aims Clinical features and outcomes in the novel phenotype heart failure with mid‐range
ejection fraction [HFmrEF, ejection fraction (EF) 40–49%] were compared with heart failure with …
ejection fraction [HFmrEF, ejection fraction (EF) 40–49%] were compared with heart failure with …
Physical activity and mortality in patients with stable coronary heart disease
Background : Recommendations for physical activity in patients with stable coronary heart
disease (CHD) are based on modest evidence. Objectives : The authors analyzed the …
disease (CHD) are based on modest evidence. Objectives : The authors analyzed the …
Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: a nationwide cohort study
Background— The pathogenic role of ischemic heart disease (IHD) in heart failure (HF) with
reduced ejection fraction (HFrEF; EF <40%) is well established, but its pathogenic and …
reduced ejection fraction (HFrEF; EF <40%) is well established, but its pathogenic and …
In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET
…, SO Granstam, S Rosengren, O Vedin… - Journal of Nuclear …, 2013 - Soc Nuclear Med
Cardiac amyloidosis is a differential diagnosis in heart failure and is associated with high
mortality. There is currently no noninvasive imaging test available for specific diagnosis. N-[…
mortality. There is currently no noninvasive imaging test available for specific diagnosis. N-[…
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
…, M Brueckmann, W Jamal, O Vedin… - European heart …, 2021 - academic.oup.com
Aims In this secondary analysis of the EMPEROR-Reduced trial, we sought to evaluate
whether the benefits of empagliflozin varied by baseline health status and how empagliflozin …
whether the benefits of empagliflozin varied by baseline health status and how empagliflozin …
Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure
G Savarese, O Vedin, D D'Amario, A Uijl, U Dahlström… - JACC: Heart Failure, 2019 - jacc.org
Objectives : This study sought to evaluate the incidence, the predictors, and the associations
with outcomes of changes in ejection fraction (EF) in heart failure (HF) patients. Background …
with outcomes of changes in ejection fraction (EF) in heart failure (HF) patients. Background …
[HTML][HTML] Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial
Background Patients with acute myocardial infarction (MI) are at risk for developing heart
failure (HF) and subsequently are at an increased risk of mortality. Sodium-glucose …
failure (HF) and subsequently are at an increased risk of mortality. Sodium-glucose …
Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, and prognostic and therapeutic implications
D Stolfo, A Uijl, O Vedin, A Strömberg, UL Faxén… - JACC: Heart Failure, 2019 - jacc.org
Objectives : This study assessed sex-related differences in a large cohort of unselected patients
with heart failure (HF) across the ejection fraction (EF) spectrum. Background : Females …
with heart failure (HF) across the ejection fraction (EF) spectrum. Background : Females …
Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
…, E Lonn, A Stebbins, K Chiswell, O Vedin… - European heart …, 2016 - academic.oup.com
Objectives To determine whether dietary pattern assessed by a simple self-administered
food frequency questionnaire is associated with major adverse cardiovascular events (MACE) …
food frequency questionnaire is associated with major adverse cardiovascular events (MACE) …